TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - AMGEN | Market Closed - Boerse Frankfurt Warrants 15:39:12 2024-06-14 EDT | ||
| 6.93 EUR | -0.29% |
|
| Current month | -8.90% | ||
| 1 month | -16.75% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-14 | 6.86 | -1.29% |
| 24-06-13 | 6.95 | -1.56% |
| 24-06-12 | 7.06 | -1.81% |
| 24-06-11 | 7.19 | -3.88% |
| 24-06-10 | 7.48 | -1.32% |
Real-time Boerse Frankfurt Warrants
Last update June 14, 2024 at 03:39 pm
More quotesStatic data
| Product type | Knock-Out ohne Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SD4L9W |
| ISIN | DE000SD4L9W8 |
| Date issued | 2021-03-12 |
| Strike | 225.4 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 3.69 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.09 € |
|---|---|
| Lowest since issue | 0.61 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
298.6
USD
Average target price
316.4
USD
Spread / Average Target
+5.97%
- Stock Market
- Certificates
- Certificat
